Search
for
Sort by
Research 931–960 of 1000+
- Effects of recombinant human keratinocyte growth factor-2 on hair regeneration in experimental bald rats
- Enhanced Iontophoretic Delivery of Magnesium Ascorbyl 2-Phosphate and Sodium Fluorescein to Hairless and Hairy Mouse Skin
- 1424 METHYLATION AND DECREASED EXPRESSION OF 5-ALPHA REDUCTASE 2 IN HUMAN PROSATE SAMPLES: IMPLICATIONS FOR RESISTANCE TO THERAPY FOR BPH
- 생발음(生髮飮)-2 피부도포가 C57BL/6 마우스의 육모촉진에 미치는 효과
- Identification of Pygopus 2 as a component of the ribosomal RNA transcription complex in cancer
- ASCORBIC ACID 2-PHOSPHATE PROMOTES HAIR GROWTH
- 1640: Polymorphisms in the 5α-Reductase Type 2 Gene and Response to Finasteride Treatment in BPH
- Cost-minimization Analysis of 2 Drug Therapy Projects Including Traditional Chinese Medcines and Chemical Medcines in BPH Patients
- ポ-トフォリオを使った社会科教育法の授業実践--ポ-トフォリオによるカリキュラム改革と教師の力量形成(2)
- The use of 2 percent minoxidil with hair transplants
- The Acute Toxicity of 2,3,4,7,8-Pentachlorodibenzofuran (4PeCDF) in the Male Fischer Rat
- 1342 Spatial transcriptome profiling reveals TGFβ-2 in hair follicle progenitor cells is a potential driver of androgenetic alopecia
- Successful treatment of hereditary hypotrichosis simplex by platelet rich plasma injection with topical minoxidil 2%
- SARS-CoV-2 vaccination in androgen sensitive phenotypes – A study on associated factors for SARS-CoV-2 vaccination and its adverse effects among androgenetic alopecia and benign prostate hyperplasia patients
- Serum nuclear factor E‐2‐related factor 2 in female pattern hair loss
- Assessment of Human Nuclear Factor Erythroid 2 Related Factor 2 (NRF2) in Androgenetic Alopecia in Egyptian Men
- Methylated CpG dinucleotides in 5-α reductase 2 gene might explain the finasteride-resistance in BPE patients
- The Use of Trichoscopy to Assess the Efficacy of Topical Minoxidil 2% Solution in Patients with Female Pattern Hair Loss
- P163 : Clinical efficacy of 2.5mg/day finasteride in female pattern hair loss
- 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
- COMPARISION OF EFFECTS OF 2% TOPICAL MINOXIDIL SOLUTION WITH 20/0 TOPICAL PROGRESTERONE IN THE TREATMENT OF FEMALE PATTERN ANDROGENETIC ALOPECIA
- Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment
- First use of thymus transplantation therapy for FOXN1 deficiency (nude/SCID): a report of 2 cases
- Systemic Steroids With or Without 2% Topical Minoxidil in the Treatment of Alopecia Areata
- Comparison of viral RNA–host protein interactomes across pathogenic RNA viruses informs rapid antiviral drug discovery for SARS-CoV-2
- Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis
- Male gonadal function in coeliac disease: 2. Sex hormones.
- Genome-wide analysis of Musashi-2 targets reveals novel functions in governing epithelial cell migration
- Role of Endolysosomes in Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Coronavirus Disease 2019 Pathogenesis: Implications for Potential Treatments
- Hair Follicle Apoptosis and Bcl-2